Article

Downregulated ZNF132 Predicts Unfavorable Outcomes in Breast Cancer via Hypermethylation Modification

2020-07-06

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> An important mechanism that promoter methylation-mediated gene silencing for gene inactivation, is identified in human tumorigenesis. Although a serious of methylated genes have been found in breast cancer (BC), beneficial biomarkers for early diagnosis and prognostic assessment of this cancer remain little known. ZNF132 has been reported to be downregulated by...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9d88a060-2927-566d-9a4e-e044aff0b09d
DOI: 10.21203/rs.2.15590/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Downregulated ZNF132 Predicts Unfavorable Outcomes in Breast Cancer via Hypermethylation ModificationDOI 10.21203/rs.2.15590/v2Read

Pan-Cancer Analysis of Tumor Suppressor ZNF132 Reveals Its Diagnostic and Prognostic Significance with Immunomodulatory Implications in Colorectal CancerSemantic proximity Read

Assessment of the expression patterns of ZNF667-AS1, LINC00662, and ZFP36 and their association with breast cancer patients’ clinicopathologicalSemantic proximity Read

DNA hypermethylation of the ZNF132 gene participates in the clinicopathological aggressiveness of 'pan-negative'-type lung adenocarcinomas.Semantic proximity Read

Downregulation of zinc finger protein 132 in prostate cancer is associated with aberrant promoter hypermethylation and poor prognosisSemantic proximity Read

Detection of aberrantly methylated tumor suppressor genes in breast cancer patients as a potential diagnostic biomarkerSemantic proximity Read

Identification of differentially methylated genes as diagnostic and prognostic biomarkers of breast cancerSemantic proximity Read

LncRNA MBNL1-AS1 Represses Proliferation and Cancer Stem-Like Properties of Breast Cancer Through MBNL1-AS1/ZFP36/CENPA AxisSemantic proximity Read

ZNF133 is a potent suppressor in breast carcinogenesis through dampening L1CAM, a driver for tumor cell invasionSemantic proximity Read

YTHDF3 modulates the progression of breast cancer cells by regulating FGF2 through m6A methylationSemantic proximity Read

DNA Hypomethylation Affects Cancer-Related Biological Functions and Genes Relevant in Neuroblastoma PathogenesisSemantic proximity Read

ZNF154 is a promising diagnosis biomarker and predicts biochemical recurrence in prostate cancerSemantic proximity Read

The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker valueSemantic proximity Read